Among women diagnosed with early breast cancer, one in four will be premenopausal. In relation to breast cancer, the term “young” typically refers to patients aged less than 40 years. While breast cancer in young women is not common, breast cancer remains the leading cause of cancer deaths among young women. Only about 1 in 40 women diagnosed with breast cancer will be very young (defined here as <35 years).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adami HO, Malker B, Holmberg L, et al. The relation between survival and age at diagnosis in breast cancer. NEJM. 1986;315:559–63.
De la Rochefordiere A, Asselain B, Campana F, et al. Age as a prognostic factor in premenopausal breast cancer. Lancet. 1993;341;1039–43.
Albain K, Allred C, Clark G. Breast cancer outcome and predictors of outcome: Are there age differentials? JNCI monographs. 1994;16:35–42.
Colleoni M, Rotmensz N, Peruzzotti G, et al. Role of endocrine responsiveness and adjuvant therapy in very young (below 35 years) with operable breast cancer and node negative disease. Ann Oncol. 2006;17:1497–503.
Goldhirsch A, Glick JH, Gelber RD, et al. Meeting Highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005;16:1569–83.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;365:1687–717.
Aebi S, Gelber S, Castiglione-Gertsch M, et al. Is chemotherapy alone adequate for young women with oestrogen-receptor positive breast cancer? Lancet. 2000;355:1869–74.
Goldhirsch A, Gelber RD, Yothers G, et al. Adjuvant therapy for very young women with breast cancer: Need for tailored treatments. JNCI Monographs. 2001;30:44–51.
Pagani O, O’Neill A, Castiglione M, et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: Results of the International Breast cancer Study Group (IBCSG) Trial VI. Eur J Cancer. 1998;34:632–40.
Goldhirsch A, Gelber RD, Castiglione M. The magnitude of endocrine effect of adjuvant chemotherapy for premenopausal breast cancer patients. Ann Oncol. 1990;1:183–8.
Tancini G, Valagussa P, Bajetta E, et al. Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer. Cancer Clin Trials. 1979;2:285–92.
Cobleigh M et al. Proc Am Soc Clin Oncol. 1995;14:A158.
Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17:2365–70.
Davidson N, O’Neill AM, Vukov AM, et al. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: Results form INT 0101 (E5188). J Clin Oncol. 2005;23:5973–82.
International Breast Cancer Study Group. Adjuvant Chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial. JNCI. 2003;95:1833–46.
Love RR, Nguyen BD, Nguyen VD, et al. Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin Breast Cancer. 2002;2:294–8.
Bartelink H, Horiot JC, Poortmans P, et al. Impact of radiation dose on local control, fibrosis and survival after breast conserving treatment:10 year results of the EORTC Trial 22881-10882. Breast Cancer Res and Treat. 2006;100(suppl 1, S8).
Early Breast Cancer Trialists’ Collaborative Group. Effects of radiation and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of randomised trials. Lancet. 2005;366:2087–106.
Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol. 2006;24:2917–31.
Guinee VF, Olsson H, Moller T, et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet. 1994;343:1587–1589.
Phillips KA, Milne RL, Friedlander ML, et al. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol. 2004;22:699–705.
Dite GS, Jenkins MA, Hocking JS, et al. Familial risks, early onset breast cancer, and BRCA1 and BRCA2 germline mutations. JNCI. 2003;95:448–57.
Ganz PA, Greendale GA, Petersen L, et al. Breast cancer in younger women: Reproductive and late health effects of treatment. J Clin Oncol. 2003;21:4184–93.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Francis, P.A. (2009). Young Patients with Breast Cancer. In: Castiglione, M., Piccart, M. (eds) Adjuvant Therapy for Breast Cancer. Cancer Treatment and Research, vol 151. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75115-3_18
Download citation
DOI: https://doi.org/10.1007/978-0-387-75115-3_18
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-75114-6
Online ISBN: 978-0-387-75115-3
eBook Packages: MedicineMedicine (R0)